- Docket No.
- 24-1019
- Appellate Court
- Eighth Circuit
Goal
- Enjoin enforcement of law
- Invalidate state law
Issues
Case History
Litigation Content
Why this Matters:
The plaintiff argues that a Minnesota law prohibiting generic drug manufacturers from excessively increasing prices violates the Due Process Clause of the Fourteenth Amendment as well as the Dormant Commerce Clause. Price gouging laws are one approach states are currently pursuing to lower prescription drug costs for their residents.
Potential Impact:
The inability for state policymakers to address prescription drug affordability could negate savings for patients, and more broadly restrict state regulatory authority in the health care arena.
11 Major Filings
- RESPONSE OF APPELLEE ASSOCIATION FOR ACCESSIBLE MEDICINES (Mar 21, 2025)
- DEFENDANT NOTICE OF SUPPLEMENTAL AUTHORITY (Mar 19, 2025)
- RESPONSE OF APPELLANT KEITH M. ELLISON TO 28(J) CITATION (Feb 26, 2025)
- 28(J) CITATION (Feb 24, 2025)
- Response to Notice of Supplemental Authority (Oct 16, 2024)
- Notice of Supplemental Authority (Oct 10, 2024)
- APPELLANT'S REPLY BRIEF (May 6, 2024)
- BRIEF OF APPELLEE (Apr 15, 2024)
- APPELLANT'S ADDENDUM (Feb 22, 2024)
- APPELLANT'S BRIEF (Feb 22, 2024)
- APPELLANT'S STATEMENT OF THE ISSUE (Jan 17, 2024)